RadNet, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
RadNet, Inc. (RDNT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $1.70 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2017-03-17
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-03-31 was $1.90M, a 11775.00% increase year-over-year.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-12-31 was $1.40M.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-09-30 was $0.00.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-06-30 was $5.88M.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $1.70M, a 72.58% decline from fiscal 2015.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2015 was $6.20M, a 15.07% decline from fiscal 2014.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was $7.30M, a 217.39% increase from fiscal 2013.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2013 was $2.30M, a 767.92% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $1.70M 10-K · filed 2017-03-17 | ||||
| 2015-12-31 | $6.20M 10-K · filed 2017-03-17 | ||||
| 2015-03-31 | $1.90M 10-Q · filed 2015-05-11 | $3.30M derived: sum of 2 quarters · filed 2016-03-15 | $3.30M derived: sum of 3 quarters · filed 2016-03-15 | $9.18M derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.40M derived: sum of 2 quarters · filed 2016-03-15 | $7.28M derived: sum of 3 quarters · filed 2016-03-15 | $7.30M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $5.88M derived: sum of 2 quarters · filed 2014-11-10 | $5.90M 10-Q · filed 2014-11-10 | $5.90M derived: sum of 4 quarters · filed 2015-05-11 | |
| 2014-06-30 | $5.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $5.90M 10-Q · filed 2014-08-11 | $5.90M derived: sum of 3 quarters · filed 2015-05-11 | $5.90M derived: sum of 4 quarters · filed 2015-05-11 | |
| 2014-03-31 | $16.00K 10-Q · filed 2015-05-11 | $16.00K derived: sum of 2 quarters · filed 2015-05-11 | $16.00K derived: sum of 3 quarters · filed 2015-05-11 | $16.00K derived: sum of 4 quarters · filed 2015-05-11 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $2.30M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $2.30M 10-Q · filed 2014-11-10 | $230.00K 10-Q · filed 2013-11-13 | $2.30M derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $2.30M 10-Q · filed 2014-08-11 | $2.30M derived: sum of 3 quarters · filed 2014-08-11 | ||
| 2013-03-31 | $2.30M 10-Q · filed 2014-05-12 | $2.30M derived: sum of 2 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $265.00K 10-K · filed 2014-03-17 | |||
| 2012-09-30 | $265.00K 10-Q · filed 2013-11-13 | ||||
| 2012-03-31 | $265.00K 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $606.00K 10-K · filed 2014-03-17 | ||||
| 2010-12-31 | $1.30M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |